Analysis of thrombophilia test ordering practices at an academic center

A proposal for appropriate testing to reduce harm and cost

Yu Min Shen, Judy Tsai, Evelyn Taiwo, Chakri Gavva, Sean Yates, Vivek Patel, Eugene Frenkel, Ravi Sarode

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which can give false positive results that may result in long term anticoagulation. However, thrombophilia testing is often performed routinely in unselected patients. We analyzed all consecutive thrombophilia testing orders during the months of October and November 2009 at an academic teaching institution. Information was extracted from electronic medical records for the following: indication, timing, comprehensiveness of tests, anticoagulation therapy at the time of testing, and confirmatory repeat testing, if any. Based on the findings of this analysis, we established local guidelines in May 2013 for appropriate thrombophilia testing, primarily to prevent testing during the acute thrombotic event or while the patient is on anticoagulation. We then evaluated ordering practices 22 months after guideline implementation. One hundred seventy-three patients were included in the study. Only 34% (58/173) had appropriate indications (unprovoked venous or arterial thrombosis or pregnancy losses). 51% (61/119) with an index clinical event were tested within one week of the event. Although 46% (79/173) were found to have abnormal results, only 46% of these had the abnormal tests repeated for confirmation with 54% potentially carrying a wrong diagnosis with long term anticoagulation. Twenty-two months after guideline implementation, there was an 84% reduction in ordered tests. Thus, this study revealed that a significant proportion of thrombophilia testing was inappropriately performed. We implemented local guidelines for thrombophilia testing for clinicians, resulting in a reduction in healthcare costs and improved patient care.

Original languageEnglish (US)
Article numbere0155326
JournalPLoS One
Volume11
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Thrombophilia
Costs and Cost Analysis
Testing
Guidelines
Costs
testing
Electronic Health Records
Health Care Costs
Electronic medical equipment
Patient Care
Teaching
Thrombosis
health care costs
Pregnancy
therapeutics
patient care
thrombosis
Therapeutics
electronics
pregnancy

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Analysis of thrombophilia test ordering practices at an academic center : A proposal for appropriate testing to reduce harm and cost. / Shen, Yu Min; Tsai, Judy; Taiwo, Evelyn; Gavva, Chakri; Yates, Sean; Patel, Vivek; Frenkel, Eugene; Sarode, Ravi.

In: PLoS One, Vol. 11, No. 5, e0155326, 01.05.2016.

Research output: Contribution to journalArticle

Shen, Yu Min ; Tsai, Judy ; Taiwo, Evelyn ; Gavva, Chakri ; Yates, Sean ; Patel, Vivek ; Frenkel, Eugene ; Sarode, Ravi. / Analysis of thrombophilia test ordering practices at an academic center : A proposal for appropriate testing to reduce harm and cost. In: PLoS One. 2016 ; Vol. 11, No. 5.
@article{a99208e4a8a747e0aa46dd8763efb191,
title = "Analysis of thrombophilia test ordering practices at an academic center: A proposal for appropriate testing to reduce harm and cost",
abstract = "Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which can give false positive results that may result in long term anticoagulation. However, thrombophilia testing is often performed routinely in unselected patients. We analyzed all consecutive thrombophilia testing orders during the months of October and November 2009 at an academic teaching institution. Information was extracted from electronic medical records for the following: indication, timing, comprehensiveness of tests, anticoagulation therapy at the time of testing, and confirmatory repeat testing, if any. Based on the findings of this analysis, we established local guidelines in May 2013 for appropriate thrombophilia testing, primarily to prevent testing during the acute thrombotic event or while the patient is on anticoagulation. We then evaluated ordering practices 22 months after guideline implementation. One hundred seventy-three patients were included in the study. Only 34{\%} (58/173) had appropriate indications (unprovoked venous or arterial thrombosis or pregnancy losses). 51{\%} (61/119) with an index clinical event were tested within one week of the event. Although 46{\%} (79/173) were found to have abnormal results, only 46{\%} of these had the abnormal tests repeated for confirmation with 54{\%} potentially carrying a wrong diagnosis with long term anticoagulation. Twenty-two months after guideline implementation, there was an 84{\%} reduction in ordered tests. Thus, this study revealed that a significant proportion of thrombophilia testing was inappropriately performed. We implemented local guidelines for thrombophilia testing for clinicians, resulting in a reduction in healthcare costs and improved patient care.",
author = "Shen, {Yu Min} and Judy Tsai and Evelyn Taiwo and Chakri Gavva and Sean Yates and Vivek Patel and Eugene Frenkel and Ravi Sarode",
year = "2016",
month = "5",
day = "1",
doi = "10.1371/journal.pone.0155326",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Analysis of thrombophilia test ordering practices at an academic center

T2 - A proposal for appropriate testing to reduce harm and cost

AU - Shen, Yu Min

AU - Tsai, Judy

AU - Taiwo, Evelyn

AU - Gavva, Chakri

AU - Yates, Sean

AU - Patel, Vivek

AU - Frenkel, Eugene

AU - Sarode, Ravi

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which can give false positive results that may result in long term anticoagulation. However, thrombophilia testing is often performed routinely in unselected patients. We analyzed all consecutive thrombophilia testing orders during the months of October and November 2009 at an academic teaching institution. Information was extracted from electronic medical records for the following: indication, timing, comprehensiveness of tests, anticoagulation therapy at the time of testing, and confirmatory repeat testing, if any. Based on the findings of this analysis, we established local guidelines in May 2013 for appropriate thrombophilia testing, primarily to prevent testing during the acute thrombotic event or while the patient is on anticoagulation. We then evaluated ordering practices 22 months after guideline implementation. One hundred seventy-three patients were included in the study. Only 34% (58/173) had appropriate indications (unprovoked venous or arterial thrombosis or pregnancy losses). 51% (61/119) with an index clinical event were tested within one week of the event. Although 46% (79/173) were found to have abnormal results, only 46% of these had the abnormal tests repeated for confirmation with 54% potentially carrying a wrong diagnosis with long term anticoagulation. Twenty-two months after guideline implementation, there was an 84% reduction in ordered tests. Thus, this study revealed that a significant proportion of thrombophilia testing was inappropriately performed. We implemented local guidelines for thrombophilia testing for clinicians, resulting in a reduction in healthcare costs and improved patient care.

AB - Ideally, thrombophilia testing should be tailored to the type of thrombotic event without the influence of anticoagulation therapy or acute phase effects which can give false positive results that may result in long term anticoagulation. However, thrombophilia testing is often performed routinely in unselected patients. We analyzed all consecutive thrombophilia testing orders during the months of October and November 2009 at an academic teaching institution. Information was extracted from electronic medical records for the following: indication, timing, comprehensiveness of tests, anticoagulation therapy at the time of testing, and confirmatory repeat testing, if any. Based on the findings of this analysis, we established local guidelines in May 2013 for appropriate thrombophilia testing, primarily to prevent testing during the acute thrombotic event or while the patient is on anticoagulation. We then evaluated ordering practices 22 months after guideline implementation. One hundred seventy-three patients were included in the study. Only 34% (58/173) had appropriate indications (unprovoked venous or arterial thrombosis or pregnancy losses). 51% (61/119) with an index clinical event were tested within one week of the event. Although 46% (79/173) were found to have abnormal results, only 46% of these had the abnormal tests repeated for confirmation with 54% potentially carrying a wrong diagnosis with long term anticoagulation. Twenty-two months after guideline implementation, there was an 84% reduction in ordered tests. Thus, this study revealed that a significant proportion of thrombophilia testing was inappropriately performed. We implemented local guidelines for thrombophilia testing for clinicians, resulting in a reduction in healthcare costs and improved patient care.

UR - http://www.scopus.com/inward/record.url?scp=84969791872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969791872&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0155326

DO - 10.1371/journal.pone.0155326

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0155326

ER -